ACON insider trading
NasdaqCM HealthcareAclarion, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Aclarion, Inc.
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Company website: www.aclarion.com
ACON insider activity at a glance
FilingIQ has scored 19 insider transactions for ACON since Apr 21, 2022. The most recent filing in our index is dated May 12, 2026.
Across the full history, 15 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ACON insider trades is 66.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ACON Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ACON?
- FilingIQ tracks 19 Form 4 insider transactions for ACON (Aclarion, Inc.), covering filings from Apr 21, 2022 onwards. 4 of those were filed in the last 90 days.
- Are ACON insiders net buyers or net sellers?
- Across the full Form 4 history for ACON, 15 transactions (79%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ACON insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ACON in?
- Aclarion, Inc. (ACON) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $7.63M.
Methodology & sources
Every ACON insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.